Skip to content

R&D at other companies

Stryker logo
StrykerSYK
$413M+2.0%
Orthofix Medical Inc. logo
Orthofix Medical Inc.OFIX
$15.32M-22.5%
Alphatec Holdings logo
Alphatec HoldingsATEC
$17.56M+5.9%
Medtronic logo
MedtronicMDT
$671M-1.9%
3D Systems logo
3D SystemsDDD
$9.64M-51.0%
SI-BONE, Inc. logo
SI-BONE, Inc.SIBN
$4.19M-7.5%

Other financials

Income statement

See full
Revenue$16.1M+58.2%
Gross profit$12.4M+62.7%
Operating income-$9.3M-62.2%
Net income-$8.7M-51.8%
EPS (diluted)-$0.32+78.2%

Balance sheet

See full
Cash & equivalents$73.0M+68.1%
Total debt$17.3M
Total equity$92.2M+220%
Total assets$118.8M

Cash flow

See full
Operating cash flow-$13.0M-59.5%
CapEx$79.0K-4.8%
Free cash flow-$13.1M-58.8%

Valuation

See full
Market cap$305.56M-20.3%
Enterprise value$249.8M
P/S5.4×

Profitability

See full
Gross margin75.9%+1.4pp
Operating margin-60.5%-10.2pp
Net margin-57.8%-11.2pp
FCF margin-61.1%

Returns & leverage

See full
Return on equity-416.9%
Debt / equity0.2×
Current ratio11.9×

Where this comes from

Reported directly by CARL in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.

The official record: CARL’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about CARL's r&d.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CARL's R&D?
CARL (CARL) reported R&D of $5.18M in Q1 2026.
How has CARL's R&D changed year-over-year?
CARL's R&D increased by 64.4% year-over-year, from $3.15M to $5.18M.
What does R&D mean?
Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.